In the intricate world of pharmaceutical development and biochemical research, the precise assembly of amino acid sequences is paramount. N-alpha-(tert-Butoxycarbonyl)-L-lysine, identified by its CAS number 13734-28-6, stands out as a cornerstone intermediate. Its unique structure, featuring protective groups on both the alpha-amino and epsilon-amino positions of lysine, makes it exceptionally valuable for controlled peptide synthesis.

The tert-butoxycarbonyl (Boc) group on the alpha-amino position and other protecting groups on the side chain allow chemists to selectively deprotect and extend peptide chains. This controlled deprotection strategy is fundamental in solid-phase peptide synthesis (SPPS), a technique widely adopted for its efficiency and scalability. By using N-alpha-(tert-Butoxycarbonyl)-L-lysine, researchers can meticulously build complex peptide structures, which are increasingly vital for developing targeted therapeutics and diagnostic tools.

The purity of such intermediates directly impacts the success of these complex syntheses. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing high-purity N-alpha-(tert-Butoxycarbonyl)-L-lysine, ensuring that researchers and manufacturers receive a reliable building block for their critical projects. The chemical properties of this compound, including its stability and solubility, are optimized for ease of use in various laboratory settings, from small-scale research to larger production batches.

The application of this amino acid derivative extends beyond basic peptide assembly. It plays a crucial role in modifying peptides to enhance their therapeutic properties, such as increasing solubility, improving bioavailability, or facilitating targeted drug delivery. The ability to buy N-alpha-Boc-L-lysine from reputable suppliers like NINGBO INNO PHARMCHEM CO.,LTD. ensures that these advancements are supported by consistent quality and availability. This intermediate is a key enabler for innovation in fields ranging from medicinal chemistry to proteomics.

As the demand for peptide-based drugs continues to grow, so does the need for high-quality pharmaceutical intermediates. N-alpha-(tert-Butoxycarbonyl)-L-lysine exemplifies the kind of specialized chemicals that drive progress in the life sciences. Understanding its chemical properties and application as a peptide synthesis building block is essential for any organization involved in advanced pharmaceutical research and development.